Aerie Pharmaceuticals downgraded
April 27, 2015 at 18:46 PM EDT
Needham downgraded Aerie Pharmaceuticals Inc. (Nasdaq: AERI) from a Buy
rating to a Hold rating sending the stock price plummeting $2.17 to
close at $10.70.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|